Skip to main content
. 2021 Mar 24;8:629874. doi: 10.3389/fmolb.2021.629874

FIGURE 4.

FIGURE 4

Pathways that targeted by cannabidiol, ketotifen, manumycin A, U0126, sulphisoxazole, and dimethyl amiloride (DMA) for inhibition of EV release.